glp-1 agonist review Frontiers GLP1 agonists: current and future

A new case report highlights the potential risk of "anhedonia" from high doses of tirzepatide, though it can be treated effectively.

Nausea Relief Right When You Need It

Medicaid coverage for weight loss medications, including GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound), varies dramatically from state to sta...

The answer is yes

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced that they have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist